EP1711490A4 - Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same - Google Patents
Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the sameInfo
- Publication number
- EP1711490A4 EP1711490A4 EP04774781A EP04774781A EP1711490A4 EP 1711490 A4 EP1711490 A4 EP 1711490A4 EP 04774781 A EP04774781 A EP 04774781A EP 04774781 A EP04774781 A EP 04774781A EP 1711490 A4 EP1711490 A4 EP 1711490A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- novel
- preparation
- pharmaceutical composition
- same
- glycoprotein inhibitor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030069803A KR100580743B1 (en) | 2003-10-08 | 2003-10-08 | A novel chromone derivative having multidrug resistance inhibitory activity or a pharmaceutically acceptable salt thereof and a preparing method thereof |
PCT/KR2004/002557 WO2005033101A1 (en) | 2003-10-08 | 2004-10-07 | Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1711490A1 EP1711490A1 (en) | 2006-10-18 |
EP1711490A4 true EP1711490A4 (en) | 2007-04-04 |
Family
ID=36968286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04774781A Withdrawn EP1711490A4 (en) | 2003-10-08 | 2004-10-07 | Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1711490A4 (en) |
KR (1) | KR100580743B1 (en) |
WO (1) | WO2005033101A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100557093B1 (en) | 2003-10-07 | 2006-03-03 | 한미약품 주식회사 | Tetrazole derivatives having inhibitory activity against multi-drug resistance and preparation thereof |
KR100724125B1 (en) * | 2005-02-24 | 2007-06-04 | 한국과학기술연구원 | Chromone Derivatives as Calpain Inhibitors and Process for the Preparation Thereof |
KR100880163B1 (en) * | 2007-05-30 | 2009-02-04 | (주)바이오버드 | Novel Multidrug Resistance Inhibitory Compound and Pharmaceutical Composition Comprising the Same |
CA3069809A1 (en) | 2017-07-14 | 2019-01-17 | University Of Massachusetts | Methods and compositions for treating inflammation |
AU2019395284A1 (en) | 2018-12-14 | 2021-06-24 | Athenex HK Innovative Limited | Therapeutic combinations of orally administered irinotecan and a P-gp Inhibitor for the treatment of cancer |
CN111732567B (en) * | 2020-06-17 | 2022-07-08 | 遵义医科大学 | Chromone framework-containing polycyclic compound, and preparation method and application thereof |
MX2023003927A (en) * | 2020-10-07 | 2023-07-05 | Athenex Inc | Acetamido-phenylbenzamide derivatives and methods of using the same. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6011069A (en) * | 1995-12-26 | 2000-01-04 | Nisshin Flour Milling Co., Ltd. | Multidrug resistance inhibitors |
GB9717576D0 (en) * | 1997-08-19 | 1997-10-22 | Xenova Ltd | Pharmaceutical compounds |
US6693099B2 (en) * | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
KR100503161B1 (en) * | 2002-07-18 | 2005-07-25 | 한미약품 주식회사 | Novel p-glycoprotein inhibitor, method for preparing same and oral composition comprising same |
-
2003
- 2003-10-08 KR KR1020030069803A patent/KR100580743B1/en not_active IP Right Cessation
-
2004
- 2004-10-07 WO PCT/KR2004/002557 patent/WO2005033101A1/en active Application Filing
- 2004-10-07 EP EP04774781A patent/EP1711490A4/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
No further relevant documents disclosed * |
Also Published As
Publication number | Publication date |
---|---|
WO2005033101A1 (en) | 2005-04-14 |
KR20050034024A (en) | 2005-04-14 |
KR100580743B1 (en) | 2006-05-15 |
EP1711490A1 (en) | 2006-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1167332A1 (en) | Pharmaceutical composition, use thereof and method for making the same | |
IL165977A (en) | Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same | |
AU2003291103A8 (en) | Pharmaceutical composition | |
IL175300A0 (en) | Indirubin-type compounds, compositions, and methods for their use | |
IL174479A (en) | Hemiasterlin derivatives, pharmaceutical compositions comprising the same and uses thereof | |
IL197889A (en) | Pyridylvinylazacyclopentane compound and pharmaceutical compositions comprising same | |
HU0301154D0 (en) | Pharmaceutical composition | |
GB0300427D0 (en) | Pharmaceutical composition | |
AU2003250372A8 (en) | Pharmaceutical composition | |
EP1765373A4 (en) | Ozonidzed pharmaceutical composition and method | |
GB0307866D0 (en) | Pharmaceutical composition | |
HK1090356A1 (en) | 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them | |
EP1699458A4 (en) | Pharmaceutical composition | |
GB0329232D0 (en) | Pharmaceutical composition | |
GB0317663D0 (en) | Pharmaceutical composition | |
IL181216A0 (en) | 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same | |
EP1482937A4 (en) | Novel tyloindicines and related processes, pharmaceutical compositions and methods | |
PL374761A1 (en) | N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them | |
EP1711490A4 (en) | Novel p-glycoprotein inhibitor, method for the preparation thereof and pharmaceutical composition comprising the same | |
GB0300885D0 (en) | Pharmaceutical composition | |
GB0306933D0 (en) | Pharmaceutical composition | |
GB0307869D0 (en) | Pharmaceutical composition | |
EP1515960A4 (en) | 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same | |
GB0307862D0 (en) | Pharmaceutical composition | |
AU2003281533A1 (en) | Novel p-glycoprotein inhibitor, method for preparing same and oral composition comprising same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060814 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20070301 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1093204 Country of ref document: HK |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20100212 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1093204 Country of ref document: HK |